Scottish women file lawsuits over contraception shot's side effects

A rising number of women in Scotland and beyond are coming forward with grave health issues related to the contraceptive injection Depo-Provera, as lawsuits against pharmaceutical giant Pfizer continue to increase. 

The cases, some involving diagnoses of brain tumors, ignite urgent questions about the safety of hormonal contraception and the sufficiency of informed consent for women prescribed these drugs. 

Key Takeaways:

• Numerous women have filed lawsuits against Pfizer after being diagnosed with brain tumors.

• Other reported complications include eye abnormalities, vision problems, and seizures.

• There have been many similar lawsuits regarding complications of Depo-Provera.

The Details:

According to reports from Scottish media outlets, various women have filed lawsuits against Pfizer after being diagnosed with intracranial meningiomas, a kind of brain tumor, after using Depo-Provera.

The injectable contraceptive, administered every three months, contains medroxyprogesterone acetate, a synthetic hormone designed to suppress ovulation. 

A number of women have experienced other serious health complications, including eye abnormalities, vision impairment, and seizures. These individuals maintain that they were not informed of the possible risks before taking the contraceptive. 

Some have claimed that they were prescribed Depo-Provera for years without being notified of any associated with tumor growth, only realizing the possible connection after learning of their serious health diagnoses. 

• Tammy Croston, a 47-year-old from Cupar in Fife, experienced partial blindness after starting Depo-Provera in 1999. She took the injection intermittently over a number of years before doctors found four benign tumors in her brain. Complications resulting from the surgery to remove one of them led to the loss of vision and function in her right eye. 

• Kirsty Moore of Dundee suffered from a bulging eye and a brain tumor after taking the injections for more than two decades. Moore was diagnosed with a benign tumor in 2021 after experiencing persistent headaches and discovering a swelling in her right eye. Since then, she has undergone four surgical procedures to remove the growth, which is located on her optic nerve. Yet in spite of several repeated operations and ongoing medical care, the tumor has continued to recur. 

Regarding the escalating number of cases of Scottish women affected by Depo-Provera, Croston said: 

This number is worrying and will only continue to grow the more people find out about the jab's link to brain tumours. This case is really going to exceed everyone's expectations. When women who have been on this jab who have tumours realise the direct correlation, it will only escalate further. It's time for Pfizer to be held accountable.

Zoom In:

A 2024 study released in the British Medical Journal disclosed that long-term use of Depo-Provera is linked to a dramatically higher risk of developing meningioma brain tumors.

Legal firms representing affected women allege that Pfizer failed to adequately warn patients of the potential risks associated with long-term use of the drug. Patrick McGuire, senior partner at Thompsons Solicitors Scotland, admitted that the firm has been contacted by over 100 women throughout Scotland, and is currently acting on behalf of more than 50 of them. 

“We’ve been inundated by calls,” McGuire said.

“It’s quite shocking when you think that many Scottish women have been affected over the years, who’ve for years simply been suffering in silence. It’s certainly the biggest, quickest uptake I have seen in any of the group actions that I’ve ever been involved in,” the attorney added. 

McGuire also outlined his objectives about the outcome he seeks from Pfizer on behalf of the claimants, saying, “They should apologise, they should stand up, they should admit they’re wrong and they should pay each and every victim of this scandal fair and just compensation.” 

The Big Picture:

The Scottish cases are part of a broader international wave of litigation. In the United States, over 1,000 lawsuits have reportedly been filed against Pfizer over similar claims. Plaintiffs contend that Pfizer either knew, or should have known, about the link between the Depo-Provera and meningioma development, but did not adequately inform healthcare providers or patients about the risks. 

Medical studies have divulged the relationship between synthetic progestins and tumor growth. Although meningiomas are often benign, their location in the brain can cause profound complications, such as seizures, vision loss, and neurological impairment. In some cases, surgery is required, with its own set of substantial risks.

For the women affected by Depo-Provera, the ramifications have been serious. Several have reported long-term health issues, job loss, and emotional trauma. 

Pfizer, however, has not conceded liability in these cases. As with many pharmaceutical lawsuits, determining causation and corporate responsibility will likely entail complex scientific and regulatory arguments. 

The Bottom Line:

The situation brings to light once again the moral questionability of contraception itself. Depo-Provera has long been contentious, not only for its health risks, but also for its potential early abortifacient effects, as it may deter the implantation of a newly-created human being.